Lb Pharmaceuticals (LBRX) Change in Acquisitions & Divestments (2024 - 2025)
Lb Pharmaceuticals' quarterly Change in Acquisitions & Divestments came in at $1000.0 in Q4 2025, down 99.99% year-on-year from $7.3 million in Q4 2024, and down 99.96% quarter-over-quarter from $2.5 million in Q1 2025.
Lb Pharmaceuticals has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $1000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 99.99% year-over-year to $1000.0; the trailing twelve-month figure through Mar 2026 stood at $9.8 million (changed N/A YoY), and the FY2025 full-year result was $2.5 million, down 91.69% from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 stood at $1000.0, down from $2.5 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $7.3 million in Q4 2024, with the low at $1000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 7.27 Mn |
| Dec 31, 2024 | 7.27 Mn |